Imatinib mesylate--the new gold standard for treatment of chronic myeloid leukemia

N Engl J Med. 2003 Mar 13;348(11):1048-50. doi: 10.1056/NEJMe030009.
No abstract available

Publication types

  • Comment

MeSH terms

  • Algorithms
  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Interferon-alpha / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Stem Cell Transplantation*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Interferon-alpha
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate